Table 2 Edge partitions of anticancer drugs.
Drugs | (1, 1) | (1, 2) | (1, 3) | (1, 4) | (2, 2) | (2, 3) | (2, 4) | (3, 3) | (3, 4) | (4, 4) |
|---|---|---|---|---|---|---|---|---|---|---|
Afatinib | 0 | 0 | 5 | 0 | 8 | 20 | 0 | 4 | 0 | 0 |
Alpelisib | 0 | 0 | 4 | 5 | 4 | 12 | 0 | 5 | 1 | 1 |
Anastrozole | 0 | 2 | 0 | 4 | 3 | 10 | 2 | 0 | 2 | 0 |
Belinostat | 0 | 1 | 1 | 2 | 7 | 10 | 1 | 0 | 1 | 0 |
Bortezomib | 0 | 0 | 6 | 0 | 8 | 12 | 0 | 3 | 0 | 0 |
Busulfan | 0 | 0 | 0 | 6 | 5 | 0 | 2 | 0 | 0 | 0 |
Carmustine | 0 | 3 | 1 | 0 | 3 | 3 | 0 | 1 | 0 | 0 |
Dasatinib | 0 | 1 | 4 | 0 | 6 | 21 | 0 | 4 | 0 | 0 |
Daunorubicin | 0 | 1 | 9 | 1 | 2 | 11 | 2 | 15 | 1 | 0 |
Erdafitinib | 0 | 2 | 3 | 0 | 5 | 22 | 0 | 4 | 0 | 0 |
Flutamide | 0 | 0 | 5 | 3 | 1 | 6 | 0 | 3 | 1 | 0 |
Futibatinib | 0 | 3 | 2 | 0 | 4 | 19 | 0 | 6 | 0 | 0 |
Granisetron | 0 | 0 | 3 | 0 | 5 | 12 | 0 | 6 | 0 | 0 |
Ibrutinib | 0 | 1 | 2 | 0 | 10 | 17 | 0 | 7 | 0 | 0 |
Lenalidomide | 0 | 0 | 4 | 0 | 3 | 8 | 0 | 6 | 0 | 0 |
Lomustine | 0 | 2 | 1 | 0 | 5 | 6 | 0 | 1 | 0 | 0 |
Melphalan | 0 | 2 | 3 | 0 | 4 | 8 | 0 | 2 | 0 | 0 |
Midostaurin | 0 | 1 | 3 | 1 | 11 | 12 | 1 | 20 | 2 | 0 |
Mitomycin C | 0 | 1 | 6 | 0 | 1 | 6 | 1 | 9 | 3 | 0 |
Nilotinib | 0 | 0 | 3 | 3 | 8 | 24 | 0 | 4 | 1 | 0 |
Olaparib | 0 | 0 | 4 | 0 | 8 | 16 | 0 | 8 | 0 | 0 |
Olutasidenib | 0 | 1 | 5 | 0 | 2 | 13 | 0 | 6 | 0 | 0 |
Orgovyx | 0 | 2 | 7 | 0 | 7 | 20 | 0 | 12 | 0 | 0 |
Plerixafor | 0 | 0 | 0 | 0 | 26 | 12 | 0 | 0 | 0 | 0 |
Pomalidomide | 0 | 0 | 5 | 0 | 3 | 6 | 0 | 8 | 0 | 0 |
Pralatrexate | 0 | 1 | 7 | 0 | 5 | 19 | 0 | 5 | 0 | 0 |
Prednisone | 0 | 1 | 3 | 3 | 3 | 8 | 3 | 3 | 4 | 1 |
Repotrectinib | 0 | 0 | 4 | 0 | 4 | 16 | 0 | 5 | 0 | 0 |
Ribociclib | 0 | 0 | 3 | 0 | 10 | 16 | 0 | 7 | 0 | 0 |
Zanubrutinib | 0 | 1 | 3 | 0 | 10 | 17 | 0 | 8 | 0 | 0 |
